EUVIMEDEUVIMED entdecken
Crossref

Curcumin boosts doxorubicin cytotoxicity in breast cancer cells

A. A. Siromolot, M. I. Loboda, S. I. Romaniuk, A. J. Labyntsev, I-M. M. Klymkovych, O. S. Molozhava, D. V. Kolybo

The Ukrainian Biochemical Journal · 16.06.2026 · 98 (3) · 101-111

DOI: 10.15407/ubj98.03.101 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Ukrainian Biochemical Journal, online erschienen am 16.06.2026. Verfasst von A. A. Siromolot und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer remains the leading cause of cancer mortality in women due to the resistance to chemotherapy and severe side effects of doxorubicin (Doxo). One of the approaches to overcome this problem is to search for phytocompounds that can enhance the efficacy of chemotherapy and prevent the development of side effects.

Objective

This work aimed to investigate in vitro whether the polyphenol curcumin (Cur) from turmeric (Curcuma longa) in combination with the commercial drug Doxo-HCl can enhance the cytotoxic effect of Doxo on breast cancer cell lines MDA-MB-231 and MCF-7 and to exhibit chemoprotective activity against normal HEK-293 cells.

Methods

Cell viability was assessed with MTT assay, apoptosis induction by flow cytometry with Annexin V–eGFP and PI, reactive oxygen species (ROS) generation by the DCFH-DA probe. The combination index (CI) calculation method and CompuSyn, Biosoft software were used to determine the synergism or antagonism of the components.

Results

The study revealed dose-dependent cytotoxicity, increased ROS formation, and increased morphological aberrations in cells when using the combination of Cur with Doxo-HCl compared to Doxo-HCl. Cur acted as a chemosensitizer, which synergistically enhanced the antitumor activity of Doxo-HCl while simultaneously reducing its cytotoxic effects in normal cells by reducing ROS production.

Conclusions

The use of Cur in combination with Doxo-HCl will likely reduce the effective therapeutic dose of Doxo and increase the effectiveness of breast cancer chemotherapy. Keywords: apoptosis, breast cancer cell lines, cell viability, chemosensitizer, combination index, combined treatment, curcumin, doxorubicin, oxidative stress

Zitieren

APA

Siromolot, A. A., Loboda, M. I., Romaniuk, S. I., Labyntsev, A. J., Klymkovych, I. M., Molozhava, O. S., & Kolybo, D. V. (2026). Curcumin boosts doxorubicin cytotoxicity in breast cancer cells. The Ukrainian Biochemical Journal, 98(3), 101-111. https://doi.org/10.15407/ubj98.03.101

Vancouver

Siromolot AA, Loboda MI, Romaniuk SI, Labyntsev AJ, Klymkovych IM, Molozhava OS, et al. Curcumin boosts doxorubicin cytotoxicity in breast cancer cells. The Ukrainian Biochemical Journal. 2026;98(3):101-111. doi:10.15407/ubj98.03.101

BibTeX
@article{Siromolot2026,
  author = {Siromolot, A. A. and Loboda, M. I. and Romaniuk, S. I. and Labyntsev, A. J. and Klymkovych, I-M. M. and Molozhava, O. S. and Kolybo, D. V.},
  title = {Curcumin boosts doxorubicin cytotoxicity in breast cancer cells},
  journal = {The Ukrainian Biochemical Journal},
  year = {2026},
  volume = {98},
  number = {3},
  pages = {101--111},
  doi = {10.15407/ubj98.03.101}
}
Kostenlos starten →